Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Market Closed - NYSE 01:30:02 03/09/2026 am IST			5-day change	1st Jan Change
51.68 ^USD	+1.08%		-2.05%	+39.83%

24/08	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
17/08	IMAX Posts $47 Million Global Weekend Boosted by 'The Odyssey'	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

5d4324.pVSBR0ZRwf9zcOkOBfHbTKYNDYKUNxWw0Fl77B80BI8.kw7FBDYCiolAINpASpqhHNM8W8j2dCLXtD1CnSZ8TeX9Z7UrCiW2uRQUig~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

24/08	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
24/07	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
24/07	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
24/07	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
24/07	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
16/07	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
16/07	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
10/07	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
18/05	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
04/05	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
01/05	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
23/04	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
17/04	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
27/02	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
26/02	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
26/02	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
15/12	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
08/12	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
08/12	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
08/12	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
08/12	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT
25/11	Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22	MT
24/25/24	IMAX Reports 'Superb' Q3 Results, Wedbush Says	MT
20/25/20	US Box Office Set to Rebound in Fourth Quarter, B. Riley Says	MT
22/25/22	Imax Likely to Surpass 'Peak' EBITDA Margins in Two Years, Wedbush Says	MT

More recommendations

Other Entertainment Production

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
IMAX CORPORATION		+4.52%
WARNER MUSIC GROUP CORP.		+30.1%
TKO GROUP HOLDINGS, INC.		+21.8%
BOLLORÉ SE		+17.39%
SEGA SAMMY HOLDINGS INC.		-2.49%
TOEI ANIMATION CO.,LTD.		+6.97%
TOEI COMPANY, LTD.	-	-1.01%
HAVAS N.V.		+18.19%
Average		+11.93%
Weighted average by Cap.		+18.28%